Variables | Survivors (n = 220) | Non-survivors (n = 35) | p value |
---|---|---|---|
Treatment | |||
Corticosteroids (n, %) | 197 (89.50) | 29 (82.86) | 0.254 |
Third-generation cephalosporin alone (n, %) | 101 (45.91) | 20 (57.14) | 0.274 |
Plus vancomycin regimen (n, %) | 62 (28.18) | 9 (25.71) | 0.841 |
Plus linezolid regimen (n, %) | 28 (12.73) | 5 (14.29) | 0.788 |
Other regimens (n, %) | 29 (13.18) | 1 (2.86) | 0.092 |
Delay 2 h in starting antibiotic therapy (n, %) | 64 (29.09) | 13 (37.14) | 0.105 |
Delay 6 h in starting antibiotic therapy (n, %) | 6 (2.73) | 4 (11.43) | 0.023 |
Delay in starting steroid treatment (n, %) | 19 (8.64) | 8 (22.86) | 0.011 |
Neurological complications | 92 (41.82) | 32 (91.42) | <0.001 |
Brain abscess (n, %) | 7 (3.18) | 2 (5.71) | 0.435 |
Cerebritis (n, %) | 12 (5.45) | 3 (8.57) | 0.442 |
Epilepsy (n, %) | 36 (16.36) | 9 (25.71) | 0.151 |
Ischemic stroke (n, %) | 24 (10.91) | 6 (17.14) | 0.228 |
Brain edema (n, %) | 23 (10.45) | 14 (40.00) | < 0.001 |